| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-06 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 4e-05 |